Outlook Therapeutics, Inc. (OTLK) › Shares OutstandingOutlook Therapeutics, Inc. (OTLK) — Shares OutstandingAnnual figures by period end, from SEC filings.2015-09-30: 9.44M2016-09-30: 22.80M2017-09-30: 24.93M2018-09-30: 9.03M2019-09-30: 28.61M2020-09-30: 127.18M2021-09-30: 176.46M2022-09-30: 227.31M2023-09-30: 13.01M2024-09-30: 23.91M2025-09-30: 53.89M53.89M2015-09-30Shares Outstanding (shares)2025-09-30Period endedShares OutstandingChange YoYSource filing2025-09-3053.89M+125.4%2025-12-19Balance as of period end2024-09-3023.91M+83.7%2025-12-19Balance as of period end2023-09-3013.01M-94.3%2024-12-27Balance as of period end2022-09-30227.31M+28.8%2023-12-22Balance as of period end2021-09-30176.46M+38.7%2022-12-29Balance as of period end2020-09-30127.18M+344.5%2021-12-23Balance as of period end2019-09-3028.61M+216.9%2020-12-23Balance as of period end2018-09-309.03M-63.8%2019-12-19Balance as of period end2017-09-3024.93M+9.3%2018-12-18Balance as of period end2016-09-3022.80M+141.6%2017-12-29Balance as of period end2015-09-309.44M—2016-12-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)